- Home
- NYC vs MLSS Comparison
NYC vs MLSS Comparison
Compare NYC & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NYC | MLSS |
|---|---|---|
| Founded | 2013 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.4M | 22.9M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | NYC | MLSS |
|---|---|---|
| Price | $11.38 | $0.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 6.7K | ★ 463.2K |
| Earning Date | 03-18-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $51,688,000.00 | $8,929,517.00 |
| Revenue This Year | $8.40 | $8.95 |
| Revenue Next Year | $1.62 | $7.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.59 |
| 52 Week Low | $7.03 | $0.22 |
| 52 Week High | $16.30 | $1.35 |
Technical Indicators
Market Signals| Indicator | NYC | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 71.14 | 50.20 |
| Support Level | $9.93 | $0.22 |
| Resistance Level | $11.99 | $0.31 |
| Average True Range (ATR) | 0.75 | 0.02 |
| MACD | 0.14 | 0.00 |
| Stochastic Oscillator | 81.17 | 90.32 |
Price Performance
Historical ComparisonAbout NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.